Grifols, S.A. (GRFS)
NASDAQ·Healthcare·Drug Manufacturers - General
$7.67
+2.34%
Mkt Cap $7.41B
No analyst coverage available
We don't have analyst ratings or price target data for Grifols, S.A. yet. Coverage gaps are common for sub-$1B market caps and recently-listed names.